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The cesarean section rate is increasing worldwide and breech presentation is with 
approximately 17 % one of the major indications for elective cesarean sections. Cesarean 
section might be a life-saving procedure for mother and child during labor, but is also a major 
procedure with possible complications and adverse long-term effects for future pregnancies. 
Breech presentation occurs in 2-3 % of term pregnancies. The safety of vaginal breech 
delivery has been questioned for a long time, as a trial of vaginal breech labor is associated 
with an increased adverse short-term outcome. The randomized Term Breech Trial by 
Hannah has had a significant effect on the handling of breech labor at term. It showed that 
vaginal breech labor at term is associated with an increased perinatal mortality and morbidity. 
However, many questioned the results of the Term Breech Trial as it violated many of its 
own criteria. More importantly, the Presentation et Mode d'Accouchement-study 
(PREMODA) showed that a trial of delivery with the fetus in breech presentation at term is 
safe, if the women are selected carefully and the delivery is managed in a modern obstetric 
setting.  Many organizations like the American College of Obstetricians and Gynecologists 
[ACOG], the Royal College of Obstetricians and Gynaecologists [RCOG], the Society 
of Obstetricians and Gynaecologists of Canada [SOGC] and the Deutsche Gesellschaft für 
Gynäkologie und Geburtshilfe [DGGG] have guidelines for selecting and managing women 
suitable for vaginal breech labor, but even then adverse outcomes are possible. 
 
Our study was designed to evaluate the potential pathophysiology of breech presentation 
itself, to look for unidentified risk factors associated with adverse perinatal outcome and to 
investigate if a trial of vaginal labor at term with the fetus in breech position, is associated 
with adverse neurodevelopmental outcome in the children at the age of four. Two of our 
studies (II and III) were conducted in the Department of Obstetrics and Gynecology of the 
Helsinki University Central Hospital as retrospective observational studies. The study periods 
were between 2011 and 2013 (II) and 2008 and 2015 (III). The data for these two studies on 
population characteristics, pregnancy and delivery outcomes were collected from the hospital 
records. The other three studies (I, IV and V) were conducted as population-based, cohort and 
record linkage studies, with data received from the National Medical Birth Register and the 
Hospital Discharge Register, maintained by the National Institute for Health and Welfare. 
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The study periods were between 2004 and 2014. Study I and IV were conducted as 
population cohort studies and study V as a population-based, record linkage study. 
 
The main outcome of study I was to show the association of possible obstetric risk factors for 
adverse outcome with breech presentation at term. In study II the main outcome was perinatal 
morbidity and mortality after an induction of labor while the fetus was in breech presentation. 
For study III and IV the main outcomes were risk factors associated with adverse perinatal 
and early neonatal outcomes in vaginal breech delivery at term. In study V we reviewed the 
neurological development of children at the age of four years born vaginally or after a trial of 
vaginal delivery in breech presentation. The key findings of our studies were as follows: The 
data of study I showed that the breech presentation rate at term in Finland is 2.2 %. Breech 
presentation is compared with vertex presentation associated with a higher stillbirth rate 
(odds ratio [OR] 2.12, 95 % confidence interval [CI] 1.98 – 2.28), fetal growth restriction 
(OR 1.19, 95 % CI 1.07 – 1.32), oligohydramnios (OR 1.42, 95 % CI 1.27 – 1.57), 
gestational diabetes (OR 1.06, 95 % CI 1.00 –1.13), congenital fetal abnormalities (OR 2.01, 
95 % CI 1.92–2.11) and a previous cesarean section (OR 2.13, 95 % 1.98 – 2.29). Our II 
study did not show differences in perinatal outcome in induced labors compared to 
spontaneous breech deliveries. However, a trial of induced breech labor was associated with a 
higher intrapartum cesarean section rate compared to spontaneous breech labor.  The results 
of study III showed that an active second delivery stage lasting less than 40 minutes protects 
from adverse perinatal outcome (OR 0.34, 95 % CI 0.15 – 0.79).  A higher intrapartum 
cesarean delivery rate of at least 24 % (OR 0.07, 95 % CI 0.01 – 0.34) was also associated 
with a lower rate of adverse outcome. Epidural anesthesia, instead, was associated with a 
higher risk for adverse neonatal outcome (OR 2.88, 95 % CI 1.08 – 7.70). The IV study 
confirmed fetal growth restriction as a risk factor for adverse perinatal outcome in vaginal 
breech labor (OR 2.94, 95 % CI, 1.30 – 6.67). In addition we found that oligohydramnios 
(OR 2.94, 95 % CI, 1.15 – 7.18), a previous cesarean section (OR 2.94, 95 % CI, 1.28 – 
6.77), gestational diabetes (OR 2.89, 95 % CI, 1.54 – 5.40), epidural anesthesia (OR 2.20, 95 
% CI, 1.29 – 3.75) and nulliparity (OR 1.84, 95 % CI, 1.10 – 3.08) are associated with a 
higher risk for adverse peri- and neonatal outcome. Our study V did not show any differences 
in the neurological development of children at the age of four years, which were born after a 
trial of vaginal labor with the fetus in breech presentation, compared to those born by elective 
cesarean section with the fetus in breech presentation.  
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In conclusion our studies showed that breech presentation at term is more often associated 
with other clinical factors that are per se markers for possible adverse obstetric risks. We 
showed that an active second delivery stage lasting less than 40 minutes or a higher 
intrapartum cesarean section rate of at least 25 % have a protective influence on fetal 
outcome in a trial of vaginal labor with the fetus in breech presentation. Adverse neonatal 
outcome in vaginal breech delivery was associated with oligohydramnios, fetal growth 
restriction, gestational diabetes, previous cesarean delivery, epidural anesthesia and 
nulliparity. An induction of labor while the fetus is in breech presentation is feasible. There 
were no differences in the neurological development of children born after a trial of vaginal 
breech labor at term compared to children, who were born by elective cesarean section while 
































Breech presentation is defined as a fetus in longitude presentation whose buttocks are 
adjacent to the maternal pelvis. In breech presentation the presenting part of the fetus may be 
the buttocks, one or both feet, or one or both knees. Breech presentation is categorized into 
three different main types. Fifty to seventy percent of fetuses in breech presentation at term 
are in frank breech presentation (Figure 1). Fetuses in frank breech presentation have flexed 
both hips while both knees are extended. At term five to ten percent of breech fetuses are in 
complete breech presentation, in which both the hips and knees are flexed (Figure 2). At 
term, ten to forty percent of breech fetuses are in incomplete presentation; these fetuses have 
extended one or both hips. Incomplete breech presentation (Figure 3) is associated with an 
increased risk of asphyxia, birth related injuries and umbilical cord prolapse in vaginal 
delivery (1,2). 
 
The incidence of breech presentation at birth is estimated to be between 2-4 %. In preterm 
delivery the prevalence of breech presentation is much higher: at 28 gestational weeks up to 
25 % of all fetuses are in breech presentation, at term less than 4 % of all fetuses are in 
breech presentation. Therefore, the most common reason for breech presentation in labor is 
preterm delivery (3-6). Most of the fetuses near term tend to turn spontaneously into vertex 
position, as in this position the fetus makes the best use of the intrauterine space. If the fetus 
remains in breech presentation at term, it is most likely that something prevents it from 
turning into vertex presentation (7). Breech presentation can be caused by a prevention of the 
fetal rotation (tight nuchal cord, uterus anomalies, cornal-fundal location of the placenta, 
oligohydramnios), an outstanding fetal rotation (preterm pregnancy), hypermobility of the 
fetus and disturbed engagement of the fetal head into the maternal pelvis (abnormal maternal 
pelvis, fetal malformation) (3-6,8-10). The reason for breech presentation at term can only be 
identified in about 15 % of the cases (11). Many clinical factors besides preterm gestation are 
frequently associated with breech presentation such as breech presentation in a previous 
pregnancy, primiparity, congenital fetal anomalies, oligohydramnios, fetal growth restriction, 
placenta previa, and maternal uterine anomalies (3-6,8-10). Since many of these factors are 
associated with independent and individual risk for poor obstetric outcome, it is possible that 
these factors might have an influence on the higher short-term morbidity rate in vaginal 




It is commonly accepted that fetuses in breech presentation are at higher risk for birth injuries 
and birth asphyxia during vaginal delivery than fetuses in vertex presentation. The safety of 
vaginal breech delivery has been debated regularly over the last decades. The term breech 
trial by Hannah, which was conducted in 2000 is one of the reasons for this (12), as the trial 
recommended delivery by cesarean section for all fetuses in breech presentation (12). To 
minimize the risk of adverse outcomes in vaginal breech delivery, different strategies have 
evolved to manage fetuses in breech presentation at term.  
External cephalic version at or near term is the most frequent strategy to minimize the risks 
of breech delivery, by reducing the incidence rate of breech presentation at term. The success 
rate of the external cephalic version varies considerably depending on the skill of the person 
carrying out the maneuver and certain, identified maternal factors (13-16). The successful 
rotation of the fetus is followed by vaginal labor but women who had a successful external 
cephalic version are at increased risk of cesarean section (17). In case of an unsuccessful 
rotation into vertex presentation a planned cesarean section is the most common way of 
delivery in many countries (18). However, in case of an unsuccessful external version a trial 
of vaginal breech labor is also possible, if the women and the fetus are well selected for a trial 
of vaginal breech labor. A cesarean section should be offered to all high-risk pregnancies and 
any women that do not wish to attempt a vaginal breech birth. An elective cesarean delivery, 
without a trial of external version is also an option for women that do not want to have an 
external version or a trial of vaginal labor. A trial of vaginal labor without a trial of external 
version is possible, if the woman and the fetus fit the criteria for vaginal breech labor.  
Malpresentation of the fetus is one of the main indications for primary cesarean section (18). 
Cesarean birth is associated with adverse maternal short and long-term outcomes (19-22). 
Recent studies assume that a cesarean birth affects the immunological development of the 
infant (23-27) and might be associated with a modestly increased risk in later life of atopic 
diseases (asthma, allergies and atopic skin disorders), diabetes mellitus type I, obesity and 
neuropsychological disorders (disorders in the autism spectrum, depressions and Parkinson 
diseases) (23-27). Various criteria have been developed to minimize the risks for adverse 
outcome in vaginal breech labor and are well described by many guidelines (28-31) and 
studies (32-36). Typically these guidelines include the following requirements (28-
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31,33,34,37-41): 1. The mother is willing to have a trial of vaginal breech labor. 2. The fetus
has no anomalies, which might cause dystocia. 3. The maternal pelvis is confirmed to be 
sufficient in size. 4. The estimated fetal weight is less than 4000 g evaluated by ultrasound
and above 2500g. 5. The fetus is in frank, or complete breech position with the head in flexed 
position.  6. The mother has not had previous cesarean deliveries. 7. The fetus does not suffer 
from an intrauterine growth restriction. All breech deliveries should be handled or guided by 
skilled staff.  
Some studies, however, have reported an increased risk of perinatal mortality and morbidity 
following a trial of vaginal breech labor (12,42-45). Adverse perinatal outcomes in vaginal 
breech delivery can be caused by complications that are typical for a vaginal breech delivery
including umbilical cord prolapse and entrapment of the fetal head, or by prenatal factors like 
fetal growth restriction, congenital anomalies, and placenta insufficiency (31). These prenatal 
risk factors for adverse prenatal outcome can sometimes be the cause for breech presentation 
as they might prevent the fetus from rotation into vertex presentation during pregnancy (7).
The present study was designed to investigate the pathophysiology of breech presentation and 
to investigate the safety of a trial of vaginal breech labor at term. We specifically focused on 
risk factors that put the fetus at risk for adverse outcome during pregnancy and labor. In 
addition, we investigated the long-term neurological effects on children born after a trial of 
vaginal breech labor at term.
Figure 1: Frank breech presentation 
 
© PJ Macharey 
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Figure 2: Complete breech presentation 
 
Figure 3: Incomplete breech presentation
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LITERATURE REVIEW  
Epidemiology 
Prevalence of breech presentation in the population  
Breech presentation occurs in 2–4 % of all births (Table 1). In Finland the prevalence of 
breech presentation in singleton pregnancies at term is between 2.1 % and 3.6 %  
(42,46). The rate is comparable with the rates in other western, developed countries 
(4,5,9,10,43,47-49)  (Table 1).  
 
The prevalence of breech presentation varies from year to year: in Australia it declined 
from 3.6 % in 2002 to 2.7 % in 2012 (10) while it increased in Norway between 1967 and 
1994 from 2.2 % to 3.4 % (47). The fluctuation in prevalence might be caused by an 
increase of the risk factors for breech presentation, such as increased maternal age, 
nulliparity, low gestational age (more premature deliveries) and a low birth weight. 
Another reason for the fluctuation might be a possible increase in the rate of external 
vertex versions (10,50). 
 
Table 1: Prevalence of breech presentation at birth (4,5,9,42,43,46,47,49,51,52)  
 Prevalence of 
breech presentation 
Country Study period 
Kauppila 3.6 % Finland 1952-1970 
Albrechtsen 2.2-3.4 % Norway 1967-1994 
Rayl 2.5 % USA 1987-1988 
Ulander* 2.1 % Finland 1987-1989 
Herbst* 2.8 % Sweden 1991-1999 
Zsirai* 3.3 % Hungary 1996-2011 
Vlemmix* 4.4 % Netherland 1999-2007 
Cammu 4.2 % Belgium 2001-2010 
Bin* 3.6-2.7 % Australia 2002-2012 
Lyons* 2.6 % Canada 2003-2011 
*





Etiology and pathogenesis of breech presentation 
It is normal for the fetus to be in breech or in any other presentation during pregnancy 
and it is also normal that the fetus changes its presentation during pregnancy. Most of the 
fetuses turn spontaneously and remain in vertex position, as it is the most efficient use of 
intrauterine space. The possibility that the fetus rotates spontaneously from breech into vertex 
presentation before gestational week 32 is around 70 %, but the chance of a spontaneous 
rotation decreases with increasing gestational weeks (53,54). Therefore, the most common 
reason for breech presentation during labor is preterm delivery, as up to 35 % of all 
preterm fetuses are in breech position (3-6). 
 
If the fetus remains in breech presentation at term, it is likely that there is a reason 
preventing the rotation of the fetus into vertex presentation (Table 2). The factors that 
increase the risk of breech presentation are well described, and might be related to an 
outstanding fetal rotation into vertex presentation, an impediment of fetal rotation or 
abnormal fetal movements. Preterm gestation is often the cause for an outstanding fetal 
rotation. Oligohydramnios, a cornual-fundal placenta, uterine abnormalities, an abnormal 
maternal pelvis or a firmer uterus and abdominal wall like in nulliparous women might 
cause an impediment to fetal rotation. Reduced fetal movements might also be the cause 
for breech presentation. Female fetuses, fetuses with congenital anomalies or growth 
restriction move less than male or healthy fetuses. A study reviewing newborns with 
myelomeningocele has shown that one quarter is born in breech presentation (55). 
Reduced fetal movements might also be caused by a short umbilical cord or maternal 
morbidity or intoxication (diabetes, preeclampsia, smoking). A polyhydramnios on the 
other hand might cause a hypermobility of the fetus and the fetus might be more 
comfortable in breech presentation as the intrauterine space is not so limited. 
Multiparous women might have a less firm abdominal wall and uterus which gives the 
fetus also more space and comfort to remain in breech presentation. Breech presentation 
may also occur if the engagement of the fetal head into the maternal pelvis is disturbed. 






Table 2: Predictive factors for breech presentation in singleton pregnancies 





















Preterm gestation 1.53-4.13  X X     Outstanding fetal rotation 
Nullipara 1.5   X     Impediment of fetal rotation 
Fetal growth restriction  1.18-1.93 1.11 X X      
Female fetus  1.28 1.20  X     Abnormal fetal movements 
Congenital malformations 1.24 1.64 X      Abnormal fetal movements 
Maternal age above 30 1.28-1.47 1.04 X X     Abnormal fetal movements 
Oligohydramnios   X      Impediment of fetal rotation 
Polyhydramnios         Abnormal fetal movements 
Diabetes  1.13 X      Abnormal fetal movements 
Prior stillbirth   1.26        
Assisted reproduction  1.19        
Cornual-fundal placenta     X    Impediment of fetal rotation 
Hypertension/Preeclampsia  1.11       Abnormal fetal movements 
Maternal smoking   X      Abnormal fetal movements 
Multiparity         Abnormal fetal movements 
Fetal neurologic impairment         Abnormal fetal movements 
Short umbilical cord          Abnormal fetal movements 
Fetal asphyxia         Abnormal fetal movements 
Earlier caesaren delivery 1.44         
Previous breech presentation       X   
Uterine abnormality/ 
Abnormal maternal pelvis 
     X  X Impediment of fetal rotation 
* Odds Ratio (OR) in comparison to vertex presentation at delivery 
X predictors for breech presentation 
 
Signs and diagnosis of breech presentation 
Women with a fetus in breech presentation can often feel the head of the fetus in the upper 
abdomen. They also may sense the kicks of the fetus in their lower abdomen. In outpatient 
clinics fetal presentation is primarily assessed using a series of abdominal palpation steps 
called Leopold’s maneuvers (59). When the fetus is in breech presentation the fetal cardiac 
sounds have to be observed in a different place compared to a fetus in vertex presentation. To 
listen to the cardiac sounds, the transducer is placed on the upper abdominal wall, above the 
maternal umbilicus. During a vaginal examination, the examiner might feel an empty cavity, 
as the leading part of the fetus does not put so much pressure on the cervix as the fetal head 
in vertex presentation. When the membranes are ruptured, the examiner might feel two soft 
masses separated by a furrow. The furrow is interrupted in the center by the anus. In 
complete breech presentation the examiner will feel the fetal feet (heel and toes). If any 
doubts about the fetal presentation remain after the examination, an ultrasound examination 
should be performed, also during labor.  
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External cephalic version  
Women with a fetus in breech presentation in singleton pregnancies should be offered an 
external cephalic version (31). The external cephalic version should be performed between 
gestational weeks 35 to 37, as before 35 gestational weeks a fetus is likely to turn into a 
cephalic presentation on its own (60-62). During an external cephalic version the fetus is 
rotated from breech into vertex presentation. External cephalic version is possible with a 
forward (Figure 4) or a backward (Figure 5) somersault. The procedure improves the 
possibility of a vaginal delivery but it is contraindicated for women who need to undergo a 
cesarean section due to some other indication such as placenta previa, two or more previous 
cesarean sections, multiple gestation or severe oligohydramnios. The risk of breech 
presentation and the risk of a cesarean section are halved (relative risk [RR] 0.42, 95 % CI 
0.29-0.61 RR 0.57, 95 % CI 0.40-0.82) by a succeeded trial of external version (61-63).  
 
The success rate of an external cephalic version is estimated to be 37 to 66 % (61,62,64,65). 
A meta-analysis of 84 studies determines that the success rate of an external cephalic version 
is at 58 % (60).  The success rate varies considerably depending on the skill of the health care 
professional carrying out the maneuver and several maternal factors (13-16). The success rate 
for multiparous women is higher than for nulliparous women (60,64). Factors associated with 
a lower success rate include: Nulliparity, anterior placenta, oligohydramnios, low birth 
weight, maternal obesity, descended buttocks into the maternal pelvis, firm maternal 
abdominal muscles and tense uterus as well as frank breech presentation (60,65-73). 
 
A systematic review (72) of 37 articles reported that external cephalic version is associated 
with minor complications: Transient fetal heart rate changes 4.7 %, feto-maternal transfusion 
0.9 %, emergency cesarean delivery 0.4 %, vaginal bleeding 0.3 %, rupture of membranes 0.2 
%, fetal death 0.2 %, placental abruption 0.2 % and cord prolapse 0.2 % (52). External 
cephalic version might increase the risk of preterm labor (RR 1.51, 95 % CI 1.03 to 2.21) 
(61,62). A meta-analysis of three cohort studies and eight case-control studies reported that 
women with a trial of vaginal labor after successful external cephalic version have an 
increased risk of emergency cesarean section compared to women with a fetus in spontaneous 
vertex presentation (OR 2.2, 95 % CI 1.6-3.0) (63). The increased frequency in emergency 
cesarean delivery is due to dystocia in labor and pathologic fetal heart rate patterns (63). 
Factors associated primarily with breech presentation like unengaged buttocks, small 
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maternal pelvis might be causes for dystocia during vaginal labor after successful external 
cephalic version (63,74). The increased rate in pathologic fetal heart rates is most likely 
explainable with the increased rate of fetal growth restriction and oligohydramnios in breech 
presentation (63,74). 
Figure 4: External cephalic version: Forward somersault 
 
© PJ Macharey 
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Figure 5: External cephalic version. Backward somersault 
 
Strategies for delivering singleton fetuses in breech presentation at term 
Women with a singleton fetus in breech presentation at term should be informed that planned 
vaginal breech delivery is associated with a small increased risk in perinatal mortality 
compared with planned cesarean section. The perinatal mortality rate in elective cesarean 
section at gestational week 39+0 is described with 0.5/1000; and in planned vaginal breech 
labor with approximately 2.0/1000. The perinatal mortality rate in planned vertex labor is 
described with 1.0/1000 (31).  Pregnant women with a fetus in breech presentation should be 
counseled that the reduced perinatal mortality risk in planned cesarean section is caused by 
three factors: the prevention of stillbirth after 39 weeks of gestation, the prevention of risks 
during labor and delivery and the avoidance of risks of vaginal breech birth. The avoidance 
of risks of vaginal breech birth is the only risk factor that is unique to a breech fetus. The 
other two factors are also present in each planned vertex labor. (31) 
© PJ Macharey 
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The women and the obstetrician should be aware of the possible complications and economic 
costs of a cesarean section. A cesarean section is associated with an increased risk of 
maternal morbidity and mortality, however to a lesser extent than in the past. The increased 
short-term morbidity and mortality is due to hemorrhages, infections and thromboembolic 
complications.  
 
Another important fact to be considered by the women is that a history of cesarean section is 
associated with an increased risk of complications in future pregnancies. Women with earlier 
cesarean delivery have a higher risk of secondary infertility (75), placental implantation 
disorder (76), uterine rupture (77) and emergency peripartum hysterectomy (19,21,22,78). 
The uterine scar increases the risk of maternal and neonatal mortality and morbidity during 
the following pregnancies. These possible complications place both mother and future 
offspring at risk.  
 
It is important to find the balance in volume between cesarean sections and vaginal breech 
deliveries. It is necessary to identify fetuses and mothers with a risk for adverse outcome, as 
this group will benefit from an elective cesarean section. However, low-risk breech 
pregnancies should be offered a trial of vaginal delivery, as well-selected pregnancies with 
adequate intrapartum management are nearly as safe as planned vaginal vertex deliveries 
(31). 
 
The following strategies are common for delivering breech fetuses at term: 
• A trial of external vertex version before labor, with a trial of labor if the version is 
successful and a cesarean delivery if it is unsuccessful. 
• A trial of external vertex version before labor, with a trial of labor if the version is 
successful. If the version is unsuccessful, a trial of vaginal breech delivery is 
offered to women that fit the criteria for vaginal breech labor. 
• Planned cesarean section without a trial of external vertex version.  
• A trial of vaginal breech delivery without a trial of external vertex version (after 




Criteria for a trial of vaginal breech labor  
Many international associations have published guidelines for selecting patients for vaginal 
breech delivery. The criteria for a trial of labor are shown in Table 3 (28,30,31,41,79). 
 
Table 3: International guidelines and recommendations for vaginal breech labor at 
term 
RCOG 20171 HUCH 20172 DGGG 20103 SCOG 20094 CNGOF 20015 ACOG 20066 
Ultrasound if possible Pre- or early labor 
ultrasound 
Pre- or early labor 
ultrasound 
Pre- or early labor 
ultrasound 
 The decision 
regarding the 
mode of delivery 
should depend on 
the experience of 
the health care 
provider. 
The role of pelvimetry 
is unclear 
Pelvimetry Normal maternal pelvis Clinically adequate 
maternal pelvis  
 
Normal pelvimetry 
Flexed fetal neck on 
ultrasound 
 
Flexed fetal neck on 
ultrasound 
 
No disproportion of the 
fetus (HC > AC) 
 
Flexed fetal neck on 
ultrasound 
Flexed fetal neck  
 
Estimated fetal weight 
< 3800 g 
Estimated fetal weight 
< 4000 g 
Estimated fetal weight < 
3800g 
Estimated fetal 
weight < 4000 g 
Estimated fetal 
weight < 3800g 
Estimated fetal weight 
above the 10th 
percentile 
Estimated fetal weight 
above the 10th 
percentile 
Estimated fetal weight 
above the 10th percentile 
Estimated fetal 
weight above 2500g 
Estimated fetal 





No footling presentation Frank or complete 
breech 
Frank or complete 
breech 
No evidence of 
antenatal fetal 
compromise 
Acceptance of the 
patient 
Acceptance of the 
patient 
No cord presentation 
and no fetal anomaly 
that are incompatible 
with vaginal delivery 
Acceptance of the 
patient 
The hospital provides 
experienced staff in 
breech delivery. 
 
 The hospital provides 
experienced staff in 
breech delivery. 
 
The hospital provides 




The hospital provides 
emergency cesarean 
section facility 
 The hospital provides 
emergency cesarean 
section facility 




Royal College of Obstetricians and Gynaecologists [RCOG]1 
Helsinki University Central Hospital [HUCH]2 
Deutsche Gesellschaft für Gynäkologie und Geburtshilfe [DGGG]3 
Society of Obstetricians and Gynaecologists of Canada [SCOG] 4 
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These guidelines include many general recommendations for vaginal breech delivery. A pre-
labor ultrasound examination gives the possibility to assess the fetal weight, the mode of 
breech presentation, the fetal neck position, cord presentation and other obstetric risk factors. 
An adequate maternal pelvis is necessary to safeguard a smooth descent of the fetus as well 
as a smooth delivery of the fetal head. An extension of the fetal neck may compromise the 
cervical spine during birth or could lead to an entrapment of the head. It might also be a sign 
of other risk factors like neurological compromise, nuchal cord, fetal goiter or a sign of an 
abnormally formed uterus. The fetus should be in frank or complete breech position and the 
fetus should not be too large to minimize the risk of dystocia and head entrapment. Fetuses 
with growth restriction are not recommended for vaginal labor, as growth restriction is 
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associated with placental insufficiency, which is a risk factor for asphyxia. The possibility of 
an immediate cesarean section and the availability of skilled and experienced staff are 
essential for a safe trial of vaginal breech labor.  
 
Pelvimetry  
The role of pelvimetry on neonatal outcome is unclear. In many countries a pelvimetry is not 
necessary for vaginal breech labor, but in others it is part of the selection process for vaginal 
breech labor.  In the largest observational vaginal breech delivery study thus far, 82 % of the 
participating women had a pelvimetry and the study showed a favorable outcome for the 
neonates and mothers (34). Magnetic resonance imaging [MRI] seems to improve neonatal 
outcome and reduce the rate of emergency cesarean section (80-83). 
 
MRI pelvimetry is known to reduce the rate of emergency cesarean sections if patients with 
insufficient results are excluded from a trial of vaginal breech labor at term (80). A recently 
published study has shown that an interspinous diameter of ≥11 cm, together with a conjugata 



















Labor and delivery while the fetus is in breech presentation 
Labor management of breech presentation at term 
Vaginal breech delivery is associated with a higher risk of perinatal mortality and morbidity 
compared to elective cesarean section. The lower risk in cesarean section is due to three 
factors: the avoidance of stillbirth after 39 gestational weeks, the avoidance of intrapartum 
risks and the avoidance of vaginal breech delivery. Only the last mentioned is unique to 
fetuses in breech presentation (31). The question arises why neonates in breech presentation   
born vaginally suffer from adverse short-term morbidity. There are two reasons for the fetal 
hypoxia in vaginal breech delivery:  a) When the fetal bottom and the main part of the body 
are born, the uterus becomes smaller. This size reduction of the uterus results in functional 
reduction of the blood gas exchange capacity of the placenta, as the placenta is attached to a 
smaller area of the uterus than before   causing respiratory acidosis. b) During vaginal breech 
delivery the umbilical cord is compressed between the fetal skull and the maternal pelvis as 
soon as the fetal neck is visible.  This results in an acute, predominant respiratory acidosis 
from which a healthy term newborn easily recovers but not a growth restricted child (84). 
 
The rate of vaginal breech deliveries and the management of vaginal breech deliveries have 
changed during the past. Obstetric pioneers like Erich Bracht, Werner Bickenbach, Arthur 
Müller, Jørgen Løvseth, Gustav Veit and William Smellie developed maneuvers and 
techniques for safer delivery of fetuses in breech presentation (84-87). Bracht’s work led to 
the most significant reduction in breech related neonatal mortality and led to more than 30 
trials in Europe and Latin America, showing a dramatic reduction in breech related mortality 
and morbidity. Due to the development of breech delivery techniques in Europe, the vaginal 
breech delivery trial rates were as high as 84 to 87 % of all breech deliveries in the 70’s 
(88,89) and 63 to 75 % twenty years later in the 90´s (90,91). In Finland the vaginal breech 
delivery rate has been reported at 89 % in 1952 to 1961 and at 72 % 1963 to 1970. In 1987-
89 55 % of all women with a fetus in breech presentation at term underwent a trial of vaginal 
breech labor (46). In Great Britain and North America vaginal breech delivery became 
outdated early on and none of the studies performed in non-English speaking countries, were 
translated into English. At the same time cesarean section became safer, so that by 1978, 60 
% (92) of breech neonates in North America and England were born by cesarean section and 
by 1990 the rate had further increased to 85 % (92,93). In 2000 the Term Breech Trial was 
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published, a large randomized trial including 121 centers from around the world, reviewing 
the outcome of vaginal breech delivery at term versus elective cesarean section (12). The trial 
showed a significantly higher neonatal morbidity rate of 5 % in a trial of vaginal breech labor 
and only 1.6 % in elective cesarean section (12). After this report, vaginal breech delivery 
rates dropped dramatically, even in countries with a high previous vaginal breech delivery 
rate like the Netherlands (from 50 to 20 %) (94) and Finland (from 50 to 20 %) (Figure 12). 
However, the trial incurred harsh criticism, since its methodology was inconsistent and more 
recent studies have shown the safety of breech birth when patients are well-selected and 
deliveries well-managed (34,95). 
 
Several national societies and organizations have published guidelines for the labor and 
delivery management of the fetus in breech presentation (Table 4) (28,30,31,41,79). A 
vaginal examination and an ultrasound should be performed on admission to determine 
whether the fetus is in frank/complete breech (hips are flexed) or in incomplete breech 
position (extended legs).  The cervical status should be evaluated to monitor the progress of 
labor. In general, the amniotic membranes should be left intact, since the risk of cord 
prolapse otherwise increases (96). On the other hand cord prolapse has also been associated 
with spontaneous rupture of membranes (97).  
 
An amniotomy is not contraindicated and might be used to treat hypocontractile uterine 
activity. In case of spontaneous membrane rupture a vaginal examination should be done to 
exclude a cord prolapse (41).  The use of cardiotocography (external or fetal scalp electrode) 
is, as in other high-risk deliveries, recommended (98,99). The progress of labor should be 
monitored continuously, similarly as it is performed when the fetus is in vertex presentation. 
The use of epidural analgesia is common (41,100), even though it is still unknown if epidural 
analgesia has a negative effect on neonatal outcome (101,101-103). The use of oxytocin is 
not contraindicated; it might be used after epidural analgesia or in the latent phase of the 
delivery (41,103-105).  
 
In case of inadequate progress during the active phase of labor, a cesarean delivery should be 
performed. The passive second stage as of the fully dilated cervix up to the active pushing 
phase should not last longer than 90 minutes (41). The active pushing phase should not last 
longer than 60 minutes (34,41).  Otherwise it is recommended to perform a cesarean section. 
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Table 4: Recommendations for labor management in vaginal breech delivery 
 
RCOG 20171 HUCH 20172 DGGG 20103 SCOG 20094 
Induction of labor is not usually 
recommended 
Induction of labor is possible - Induction of labor is not 
recommended  
Augmentation only in the 
presence of epidural analgesia 
Augmentation is possible - Augmentation only in the 
presence of epidural analgesia 
Adequate descent of the breech 
in the passive second stage 
Adequate descent of the breech 
in the passive second stage  
Active second stage <60 min 
- Passive second stage < 90 min  
Active second stage <60 min 
Assistance, without traction Spontaneous or assisted breech 
delivery is acceptable. 
- Spontaneous or assisted breech 
delivery is acceptable. 
Epidural analgesia is likely to 
increase the risk of intervention 
Epidural analgesia is permitted Epidural analgesia is 
recommended  
Epidural analgesia is permitted 
Continuous electronic fetal heart 
monitoring is recommended 
 
Continuous electronic fetal heart 
monitoring 
 
Continuous electronic fetal 
heart monitoring 
 
Continuous electronic fetal heart 
monitoring 
 
- At the time of delivery of the 
after-coming head, suprapubic 
pressure should be applied 
- At the time of delivery of the 
after-coming head, suprapubic 
pressure should be applied 
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Delivery of the term breech fetus  
The delivery of a term singleton breech fetus can be spontaneous or assisted, however 
extraction should be avoided (29,31,41,84,85). In a breech delivery it is recommended to wait 
with assistance until the fetal umbilicus is expulsed (29,31,41,85).  
After the fetal umbilicus is delivered, the obstetrician may complete the delivery of the legs 
by applying pressure to the inner aspect of the knee away from the midline, so that the lower 













Figure 6: Extraction of the fetal legs 
 
 
If the fetal trunk does not rotate spontaneously, the obstetrician should assist the delivery by 
rotating the fetal trunk. Traction on the trunk is still contraindicated as it can complicate the 
delivery. The Bracht maneuver can be used to assist the delivery of a fetus in breech position. 
When the fetus’s umbilicus becomes visible the obstetrician delivers the fetus by lifting the
fetal legs and body over the maternal symphysis pubis, in addition an assistant has to push the 
fetal head into the maternal pelvis during the whole maneuver. No traction should be applied 
during the Bracht maneuver, as traction might lead to complications like nuchal arms. If the 
fetal arms are not delivered spontaneously, intervention is required. Common maneuvers for 
delivering the fetal arms are the Müller´s, Bickenbach´s, Classic´s and Løvset's maneuvers. 
In Helsinki University Central Hospital one of the most common maneuvers used for the 
extraction of the fetal arms is the Løvset's maneuver (Figure 7).  
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The fetus is held at the hips or the buttocks (caution: if the fetus is held too high at the 
abdomen an injury of the kidneys or adrenals is likely). The first shoulder is delivered by 
rotating the fetus by 180 degrees, afterwards the fetus is rotated in the opposite direction by 
another 180 degrees to deliver the other shoulder and arm. If after the maneuver the arms are 
still not delivered being trapped under the symphysis pubis, an index finger should be 
introduced into the antecubital fossa along the fetal scapula and over the shoulder. The 
operator swaps the arm down, across the fetal face and downward to the chest, at which point 
the arm can be delivered (Figure 8). (106) 
Figure 8: Delivery of the entrapped arm 
 
 
The procedure can be repeated for the other arm. In the rare case that the arms are still 
undelivered, the fetus should be rotated so that the fetal chest faces upward towards the pubic 
symphysis. This can help to extract the arms as the elbow can be moved downwards and then 
extracted. (86,106) 
In the end pressure is applied to the lower abdomen above the pubic symphysis to support the 
flexion and descent of the head (82,106). Once the hairline of the fetus is visible, the head is 
delivered, either spontaneously or with assistance. The Mauriceau-Smellie-Veit maneuver is
one of the most common maneuvers for the delivery of the head in breech presentation
(Figure 9) (87).  
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Figure 9: Mauriceau-Smellie-Veit maneuver in breech delivery 
The maneuver starts with the fetus resting on the operator’s forearm, after which the first and 
the second finger of the hand are placed on the maxilla to flex and promote the descent of the 
fetal head. The fingers of the other hand are placed around the shoulder. Then the fetal head 
is pulled downward gently until the hairline becomes visible. The fetus is raised, still astride 
the arm, until the mouth and nose are visible. The fetus is delivered in an arc rotation on top 
of the maternal abdomen, reflecting the pelvic curve. Suprapubic pressure should be applied 
as the fetal head is delivered. (82,106) 
The use of forceps to support the delivery of the after-coming head is another option in 
breech deliveries and a warrant in an emergency situation (Figure 10).  An emergency is 
identified as a failure to accomplish the delivery of the fetal head within two minutes. When 
supporting the delivery of a breech fetus by forceps, the baby is lifted with the help of a 
towel. The left forceps blade is applied first: it is held by the operator´s left hand and inserted 
horizontally into the vagina on the left side. The right hand is used to protect the soft tissue 
and to guide the blade. The right blade is held by the operator’s right hand and inserted 
horizontally to the right maternal side while the left hand is used to protect the vaginal soft 
tissue and to guide the blade. The handles should lock easily without force, otherwise they 
© PJ Macharey 
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have to be removed and reapplied. The forceps are first drawn downwards to support the
descent of the fetal head after which they are lifted upward to follow the pelvic curve and to 
deliver the fetal head. 
Figure 10: Piper-forceps breech delivery 
 
An episiotomy should only be performed in a breech delivery if required to facilitate the 
birth, but many clinicians perform routine episiotomy in breech delivery (107).   
In case of head entrapment, uterine relaxants should be applied (terbutoline or nitroglycerin). 
A symphysiotomy might be helpful in delivering the entrapped head, but is associated with a 
significant risk for the mother (41,108). The Zavanelli maneuver (replacement of the fetal 
body back in the uterus) might be a last option to save the fetus (109-112), but the procedure 
is associated with a high fetal morbidity and mortality rate especially in cephalic presentation
(113). 
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Upright position of the women during vaginal breech delivery 
In an upright position the mother kneels and is leaning on the head of the bed, or she is on all 
fours, or she stands upright. An upright position of the mother during labor seems to be 
associated with fewer interventions (114,115), fewer maternal morbidity (114,115), a shorter 
second stage of labor (115) and fewer neonatal injuries (115), but more research regarding 
the upright position of the mother during vaginal breech labor is needed. 
Failure of the fetal trunk to rotate 
If the fetal trunk fails to rotate and the fetus ends up with its head in an occiposterior position,
the fetal trunk and head have to be rotated to bring them into anterior position. Sometimes it 
is enough to put pressure to the bottom of the fetus to stop the descent during labor and the 
fetus will rotate itself. If the fetus does not rotate itself the fetal trunk has to be grasped at the 
pelvis to rotate the fetus by 180 degrees. If the fetal head remains facing the pubis it has to be 
delivered by reversed malar flexion and traction of the shoulder with the Prague maneuver 
(Figure 11) (7). 
Figure 11: Prague maneuver 
 
© PJ Macharey 
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Induction of labor while the fetus is in breech presentation 
The induction of labor is a common obstetric procedure. Up to 30 % of all pregnancies in 
developed countries are induced (116-119). An induction is normally performed for 
prolonged pregnancies (>42 weeks of gestation), maternal medical diseases like diabetes or 
preeclampsia, fetal reasons (IUGR) and rupture membranes without evidence of labor. It is 
important to induce pregnancies only for medical causes, as induction of labor is associated 
with an increased cesarean section rate (up to 50 % of induced nulliparous women have a 
cesarean section) (116-122). The induction of labor while the fetus is in breech presentation 
is controversial. Some older studies based on small sample size (123-125) did not detect 
unfeasible maternal or neonatal outcomes after the induction of labor. Recently several newer 
studies have also shown that an induction of labor in term breech presentation is not 
associated with an adverse maternal or perinatal outcome (126-129).  
 
National guidelines are indifferent regarding the induction of labor in pregnancies with the 
fetus in breech presentation. The National Institute for Health and Care Excellence UK states 
that an induction of labor while the fetus is in breech presentation should not be offered 
generally, but might be considered after the risks of it have been discussed with the mother. 
The Canadian guidelines do not recommend an induction of labor while the fetus is in breech 
presentation (41), but the authors of the guidelines do not see breech presentation as an 
absolute contraindication any longer and believe an induction might be feasible after a risk 
assessment (personal communication Andrew Kotaska 06/2014). The ACOG (40), French 
(28) and the German guidelines (30) make no recommendations regarding an induction of 
labor while the fetus is in breech presentation. No research has been published comparing the 















Outcome of pregnancies with children born in breech 
presentation at term 
Children´s short-term outcome 
Vaginal breech labor at term is controversial (Table 5). Fetuses in breech presentation at term 
are at higher risk for birth asphyxia and perinatal mortality during vaginal delivery than 
fetuses in vertex presentation (12,31,42,91). It is also commonly accepted that a planned 
cesarean section for the breech fetus is associated with a lower risk for adverse neonatal 
outcome compared to planned vaginal breech delivery (12,130). The following three factors, 
(31) are the reasons for the lower risk for adverse neonatal outcome in elective cesarean 
section:  
1. Planned cesarean section protects from the occurrence of stillbirth after 39 weeks of 
gestation, as it is normally performed in week 39 of gestation.   
2. Planned cesarean section avoids the risk of complications during labor. 
3. Planned cesarean section avoids the risks of vaginal breech delivery.  
 
Only the last reason applies to a fetus in breech presentation uniquely (31). The main risk in 
vaginal breech delivery is that the fetus suffers from respiratory acidosis, caused by the 
reduced capacity of the placenta to maintain blood exchange with the uterus after body of the 
fetus are born. The second reason for respiratory acidosis the compression of the umbilical 
cord between fetal head and maternal pelvis once the fetal neck is delivered (84). These 
complications are also most likely the reasons why decreased variability and late deceleration 
have been observed to be more prevalent in fetal cardiotocography during vaginal breech 
delivery compared to vertex delivery (99).  
 
In many countries most breech fetuses at term are born by planned cesarean section (18). The 
main reason for this is the term breech trial by Hannah (12). This trial, published in 2000 was 
a large, randomized multicenter study. It changed worldwide the management of breech labor 
overnight, including Finland (Figure 12). However, the results of the term breech trial have 
been questioned (34,41,95,131-133), as the study had major deficits. The major limitations of 
it were the inadequate selection of the women and fetuses eligible for a trial of vaginal breech 
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delivery, incomparable birth centers were included in the study and perinatal short-term 
morbidity was used as a surrogate marker for long-term neurological impairment (41,95). 
 
The PREMODA study has shown that vaginal breech labor might be safe for well-selected 
deliveries treated with caution and in a modern obstetric unit (32,34-36,46,105,134-137). The 
perinatal mortality and severe morbidity did not differ for planned cesarean section compared 
to vaginal breech labor in the PREMODA study (34). In addition two Finnish publications 
from the last decade demonstrate that vaginal breech delivery is feasible in well selected 
pregnant women (35,36). 
 
To minimize the risk of adverse neonatal outcome patients suitable for a trial of vaginal 
breech labor should be carefully selected. Patient and provider values, experience and 
preferences should also guide the choice of delivery route.  
 
Table 5: Possible risk of adverse short-term outcome in neonates after a trial of vaginal 
breech labor compared to neonates born by planned cesarean section (12,34,136): 
 Hannah 2000 (12) Goffinet 2008 (34) Vistad 2013 (136) 
 OR (95 % CI) OR (95 % CI) OR (95 % CI) 
Perinatal / neonatal death 4.33 (1.23-15.25) - 2.11 (0.63–7.01) 
Birth trauma 2.33 (0.89-6.09) 3.90 (82.40-6.34)  
Seizures 7.00 (0.86-57.00) 1.27 (0.37-4.33)  
Hypertonia 9.00 (2.08-38.89)   
Abnormal level of consciousness 2.67 (1.04-6.84)   
Apgar <7 at 5 min 3.88 (1.77-8.47) 3.20 (1.93-5.30) 7.10 (5.04–10.88) 
Apgar <4 at 5 min 9.00 (1.14-71.17) 8.92 (1.00-79.8) 4.30 (2.35–7.93) 
Cord-blood base deficit ≥15 mmol/L 3.30 (1.07-10.20)   
Cord-blood pH <7.0 6.59 (1.47-29.35)   
Intubation and ventilation >24 h 4.00 (0.44-35.85) 1.06 (0.50-2.26)  
Tube feeding >4 days 3.00 (0.60-14.90) 1.04 (0.56-1.93)  
Care in neonatal ICU >4 days 1.50 (0.42-5.33) 0.97 (0.59-1.58) 1.80 (1.51–2.17) 
Neonatal mortality and serious neonatal morbidity 3.06 (1.75-5.33) 1.10 (0.75-1.61)  




Figure 12: Numbers of vaginal breech deliveries in Finland and HUCH during 1998 -2014 
HUCH Helsinki University Central Hospital 
Long-term outcome of children 
The question of the effect of planned vaginal breech labor on the long-term outcome of 
children is unresolved. The follow up study of the Hannah´s term breech trial did not show 
significant changes in the long-term outcome of the children, except for the fact that infants 
born by planned cesarean delivery reported more medical problems at the age of two years. 
The study reported that the combined risk of death and neurodevelopmental delay was similar 
in the children of both groups at the age of two (138).  
However, some studies have shown an association between a planned vaginal breech delivery 
and adverse neurodevelopmental outcome. Vaginal breech delivery has been associated with 
epilepsy or cerebral palsy (139-142). On the other hand, it has been shown that adverse 
neurodevelopmental long-term outcome in children born in breech presentation was not 
related to intrapartum events (Table 6) (45,52,143-146), but to obstetric risk factors 
associated with breech presentation (144-146). In general cesarean section improves the 
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outcome of infants, as it protects them from most adverse intrapartum events (31). One study 
even claims that elective cesarean section protects the fetus from cerebral palsy (141). 
 
While considering long-term outcomes, it should be kept in mind that a recent study assumes 
that children born by cesarean section have a lower performance at school (147). In addition 
birth by cesarean section is suspected to affect the immunological development of infants 
(23-27,148) and is associated with a modest increase of atopic diseases (asthma, allergies and 
atopic skin disorders), diabetes mellitus type I, obesity and neuropsychological disorders 
(disorders in the autism spectrum, depressions and Parkinson’s disease) (23-27). Birth by 
cesarean section has also been associated with early breast-feeding problems like cessation of 
breastfeeding (149). 
 
Table 6: Possible risk of adverse neurodevelopmental long-term outcome in children 
born vaginal in breech presentation compared to children born by planned cesarean 
section 
 
 Whyte 2004 (138)  Danielian 1996 
(143)  
  









 OR (95 % CI) OR (95 % CI) RR (95 % CI) OR (95 % CI) OR (95 % CI) OR (95 % CI) 
Neurodevelopmental  delay 1.09 (0.71-1.66)  - - - - 
Abnormal speech/communication  1.24 (0.54-2.83) 0.83 (0.20-0.52) - - - - 
Abnormal gross motor  1.72 (0.63-4.69) 0.18 (0.02-1.70) - - - - 
Abnormal fine motor  1.03 (0.51-2.08)  - - - - 
Abnormal problem-solving  0.71 (0.33-1.51)  - - - - 
Abnormal personal-social  1.38 (0.71-2.65)  - - - - 
Abnormal auditory 1.03 (0.06-16.44) 1.25 (0.71-2.20) - - - - 
Abnormal visually - 0.74 (0.40-1.36) - - - - 
Convulsions  - 0.45 (0.21-0.96) - - - - 
Psychiatric problems - 0.69 (0.33-1.43) - - - - 
Severe handicap - 0.49 (0.23-1.05) - - - - 
Cerebral palsy - - - 0.93 (0.40-2.15) 3.9 (1.6 – 9.7)* 3.0 (2.4 – 3.7)* 
Developmentally vulnerable  - - 1.22 (0.88–1.69) - - - 
Special needs - - 0.95 (0.48–1.88) - - - 
Low reading score  - - 1.10 (0.87–1.40) - - - 
Low numeracy score  - - 1.04 (0.81–1.34) - - - 
[OR] Odds ratio  
[RR] Relative risk  
* Significant findings 
Maternal outcome and future pregnancies 
The maternal experience of vaginal breech delivery seems to be as positive as the experience 
of women with a vaginal delivery with the fetus in vertex presentation (150). The results of 
the term breech trial of Hannah et al. did not show that planned cesarean section versus 
planned vaginal birth for breech presentation at term had an effect on the long-term maternal 
outcomes at two years (151). However, planned cesarean section was associated with a 
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higher maternal short-term morbidity, including hemorrhage, need for transfusions and 
infection (151). In addition, it carries a higher risk of postpartum depression (152) and 
women recovering from a cesarean section are reported to have a lower ability to bond with 
their children (153).  
 
The most important consequence of a cesarean section for the mother is it’s association with 
an increased risk of complications in future life. A preceding cesarean delivery is associated 
with anatomical-pathological changes of the uterus (154). Women with a cesarean scar suffer 
more often from menorrhagia, metrorraghia and dysmenorrhagia (155).  Pregnancy 
complications related to the uterine scar are common. A possible complication in next 
pregnancy might be a cesarean scar pregnancy (156). The symptoms of a cesarean scar 
pregnancy are typically vaginal bleedings and abdominal pain, but up to one third of all 
women are without any kind of symptoms (156). Other possible complications in later 
pregnancy and during labor are placental implantation disorders like placenta previa (157), 
placenta accreta, increta and percreta (76), and uterine rupture (77). Placental implantation 
disorders are significantly increased after cesarean section and might be associated with 
severe hemorrhage and surgical complications. A uterine rupture is one of the most feared 
complications during pregnancy and labor, as it is associated with increased perinatal and 
maternal morbidity and mortality. The uterine rupture risk for a woman with a scar is 4-
7/1000 deliveries, which is three times higher, compared to women without a scar (158). 
Placental implantation disorder and uterine rupture are predictors for peripartum hemorrhage 
and emergency peripartum hysterectomy (19-22,78). A cesarean scar might affect also the 
blood flow in the gravid uterus, which might have an effect on the pregnancy (161). Due to 
these possible complications the uterine scar increases the risk of maternal and neonatal 
mortality and morbidity during the following pregnancies (159,160). A cesarean section may 
also lead to reduced fertility (162). Women with a history of cesarean section have a lower 
subsequent pregnancy rate and a lower birth rate (162). They are more likely to suffer from 
secondary infertility (75). The most likely reason for this might be related to the scar tissue of 
the cesarean section (163).   Women suffering from secondary infertility often benefit from a 
treatment of the uterine isthmocele caused by a cesarean section. The treatment of the 




AIMS OF THE STUDY 
The present study was carried out to investigate the pathophysiology of breech presentation 
itself and to investigate under which circumstances a trial of vaginal breech labor at term is 
safe. The specific aims were:  
 
1. To evaluate if breech presentation itself is associated with earlier known obstetric risk 
factors. 
 
2. To evaluate delivery outcomes in pregnancies with the fetus in breech position at term 
undergoing an induction of labor. 
 
3. To assess clinical factors associated with adverse perinatal outcomes in women 
undergoing a trial of vaginal breech labor at term. 
 
4. To investigate the neurodevelopmental long-term outcome in children at the age of 
















PATIENTS AND METHODS  
Study data and design  
The data for study I, IV and V were collected from the National Medical Birth Register and 
the Hospital Discharge Register, maintained by the National Institute for Health and Welfare. 
Reporting to the national registers is mandatory for all Finnish hospitals.  Completeness and 
accuracy of the data varies from satisfactory to very good (164). The registers have a good 
nationwide coverage (164). The National Medical Birth Register contains information about 
all births (live births and stillbirths) with a birth weight of 500 g or more or with a gestational 
age of 22 weeks and beyond. The Hospital Discharge Register includes data on all inpatient 
periods in all Finnish hospitals and all outpatient visits recorded in the public sector (164). 
The registers contain demographic data, maternal information before and after the delivery, 
intrapartum procedures and complications, as well as neonatal outcome. The data collected in 
the registers is coded according to the International Statistical Classification of Diseases and 
Related Health Problems 10th Revision (ICD-10). (164)   
 
Study I was designed as a retrospective, population-based cohort. Study IV was designed as a 
retrospective population-based, case control study and the fifth study as a retrospective, 
population-based record linkage study. The National Institute of Health and Welfare 
authorized the use of the data as required by the national data protection law in Finland 
(Reference number THL/1200/5.05.00/2012). 
 
The data for studies II and III was collected in the Department of Obstetrics and Gynecology 
of Helsinki University Hospital. The Department of Obstetrics and Gynecology of the 
Helsinki University Hospital includes three different delivery departments with annually 
16.000 deliveries. The studies were conducted as retrospective, observational cohort studies. 
The regional research committee of the medical faculty of Helsinki University approved the 








Table 7: Summary of the study  
 
 Study I Study II Study III Study IV Study V 
N* 
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The study populations  
Study I  
We identified all pregnancies with a fetus in breech presentation at term from the National 
Medical Birth Register and the Hospital Discharge Register. These pregnancies were 
compared with all singleton pregnancies with the fetus in vertex presentation at term. All 
women with multiple gestation or a preterm pregnancy (< 37+0 gestational week) were 
excluded. The study period was from 2005 to 2014. (Figure 13) 
Figure 13. Flow chart of the patient selection process in study I 
 
All deliveries  in Finland (2005 - 2014) 
n = 585 580 
Excluded from the final analysis: 
multiple and 
preterm gestations  
Study I 
n = 549 614 
Fetuses in breech presentation at 
term 
n = 13 058 
Fetuses in cephalic presentation 
at term 
n = 536 556 
41 
Study II 
We identified all women with an induced labor with a singleton fetus in breech presentation 
at term. These deliveries were compared with all spontaneous vaginal breech labors with a 
singleton fetus at term. The data was collected from the maternal records of the Helsinki 
University Central Hospital (Women´s Hospital and Maternity Hospital). The study period 
was from 10/2011 to 12/2013. (Figure 14) 
Figure 14. Flow chart of the patient selection process in study II 
All singleton deliveries at term (≥37+0 gestational week) at the Women´s Hospital  
and the Maternity Hospital  
n = 24 884 
Exclusion of all deliveries with the fetus in vertex presentation   
n = 23 801 
Singleton breech deliveries 
n = 1 083 
Exclusion of preterm fetuses and multiple gestations 
n = 291 
Singleton breech deliveries at term  
n = 792 
Exclusion of 2 stillbirths, 2 children with chromosomal defects and 2 children with heart 
malformations 
Exclusion of all elective cesarean sections with the fetus in breech position  
n = 518 
Trial of vaginal breech delivery n = 268  
Trial of induced breech labor 
 n = 73 
Trial of spontaneous breech delivery 
n = 195 
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Study III 
We identified all women with a trial of labor with a singleton fetus in breech presentation at 
term. The data was collected retrospectively from the maternal records of the Helsinki 
University Central Hospital (Women´s Hospital and Maternity Hospital). Preterm deliveries, 
multiple gestations, congenital malformations, placenta previa and prelabor stillbirths were 
excluded from the study. All deliveries with a normal neonatal outcome were compared with 
all deliveries with an adverse neonatal outcome. The study period was from 2008 to 4/2015. 
(Figure 15) 
Figure 15. Flow chart of the patient selection process in study III 
All deliveries in Women´s Hospital and the Maternity Hospital  
n = 82 288   
Exclusion of preterm fetuses and multiple gestations 
n = 10 907   
Singleton deliveries at term  
n = 71 381 
Exclusion of all deliveries with the fetuses in vertex presentation n = 68 325       
Singleton breech deliveries at term  
n = 3056 
Exclusion of 2 stillbirths, 2 children with chromosomal defects and 2 children with heart 
malformations 
Exclusion of all elective cesarean sections with the fetus in breech position  
n = 2274 
Trial of vaginal breech delivery n = 776  
Adverse perinatal and neonatal outcomes 
 n = 38 
Normal perinatal and neonatal outcomes  
n = 738 
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Study IV 
We identified all women with a trial of labor with a singleton fetus in breech presentation at 
term in Finland. Preterm deliveries, multiple gestations, congenital malformations, placenta 
previa and prelabor stillbirths were excluded from the study. All deliveries with a normal 
neonatal outcome were compared with all deliveries with an adverse neonatal outcome. The 
data was collected from the National Medical Birth Register. The study period was from 
2005 to 2014. (Figure 16) 
Figure 16. Flow chart of patient selection process in study IV 
 
All deliveries  in Finland (2005 - 2014) 
n = 585 581 
Exclusion of preterms, multiple gestations, congenital malformations, placenta praevia and 
prelabor stillbirths 
n = 86 375  
Singleton fetuses at term  
n = 499 206 
Exclusion of all deliveries with the fetus in cephalic presentation  
n = 489149   
Singleton breech deliveries at term  
n = 10 057 
Vaginal labors and emergency cesarean 
sections 
 n = 4805 
Adverse perinatal 
outcome  
n = 73 
Normal perinatal 
outcome  
n = 4732 
Planned cesarean sections 
n = 5252 
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Study V  
We identified all singleton neonates born at term in breech presentation in Finland. Preterm 
deliveries, multiple gestations, congenital malformations, placenta previa and prelabor 
stillbirths were excluded from the study. All neonates that underwent a trial of vaginal breech 
labor were compared with all neonates born by elective cesarean section with the fetus in 
breech presentation. The data was collected from the National Medical Birth Register. The 
study period was from 2004 to 2010. (Figure 17) 
Figure 17. Flow chart of the patient selection process in study V 
All deliveries  in Finland (2004 - 2010) 
n = 415 526 
Exclusion of preterms, multiple gestations, congenital malformations, intrauterine growth 
restricted infants, placenta praevia, placental abruption and prelabor stillbirths 
n = 59 516 
Singleton fetuses at term  
n =  356 010 
Exclusion of all deliveries with the fetus in cephalic presentation  
n = 347 636 
Singleton breech deliveries at term  
n = 8374 
Vaginal labors and emergency cesarean 
sections 
 n = 3907 
Planned cesarean sections 
n = 4467 
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Characteristics and outcomes of the studies 
In study I the possible risk factors for adverse outcome were studied in singleton pregnancies 
with the fetus in breech presentation at term. These factors were chosen based on previous 
literature and included: maternal age, parity, maternal smoking during pregnancy, the 
maternal body mass index [BMI] > 30 kg/m2, diabetes mellitus type I, gestational diabetes, 
maternal history of cesarean section, maternal history of infertility, preeclampsia, 
oligohydramnios, placenta previa, birth weight below the two standard deviations [SD], fetal 
sex (male), birth weight in grams and congenital malformations of the fetus 
(2,33,42,46,100,115-117). (Table 8) 
 
In study II we studied the induction of labor while the fetus was in breech presentation. An 
induction of labor was defined as cervical ripening with a balloon or prostaglandin E1, an 
induction with oxytocin infusion or amniotomy. In pregnancies with an unripe cervix (Bishop 
scores < 6): labor was induced either a) with prostaglandin E1 and if necessary combined with 
an oxytocin infusion or b) a balloon catheter was used in combination with an oxytocin 
infusion if necessary. An amniotomy was performed for augmentation if necessary. Women 
with Bishop scores ≥ 6 underwent amniotomy or were induced with an oxytocin infusion, 
alone or in combination with each other. We reviewed the following characteristics: maternal 
age, nulliparity, gestational age at delivery, maternal weight and height, history of earlier 
cesarean section, maternal diabetes, epidural anesthesia, duration of the II delivery stage, 
intrapartum cesarean section, fetal sex (male) and birth weight in grams. (Table 8) 
Vaginal delivery was chosen for primary outcome. Adverse maternal and neonatal morbidity 
and mortality were chosen as secondary outcomes. (Table 9) 
 
In studies III and IV we evaluated risk factors for adverse outcome in vaginal breech labor. 
The following characteristics were studied: maternal age, nulliparity, gestational age at 
delivery, maternal smoking during pregnancy (study IV), the maternal BMI ≥ 30 kg/m2 
(study IV), gestational diabetes (study IV), maternal diabetes (study III), diabetes mellitus 
type I (study IV), diabetes mellitus type II (study IV), the maternal history of cesarean 
section, the maternal history of infertility (study IV), maternal hypertonia or preeclampsia, 
oligohydramnios (study IV), post term pregnancies (study IV), epidural anesthesia, uterine 
rupture (study IV), gender of fetus, neonatal birth weight in grams, birth weight below the < 
2SD (study IV) and above 4500g (study IV). (Table 8) 
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Adverse neonatal outcome in planned vaginal breech labor at term was defined as a 
composite index of neonatal mortality and neonatal morbidity. In study III the criteria 
included: birth trauma, seizures occurring < 24 h of neonatal age or requiring two or more 
drugs to control them, 5 min Apgar score < 4, umbilical arterial pH < 7.00, umbilical arterial 
base deficit of < -12 mmol/L, hypotonia for at least 2 h, stupor, decreased response to pain, 
neonatal coma, intubation or ventilation for at least 24h, tube feeding for > 4 days, need for 
neonatal intensive care unit [NICU] for ≥ 4 days.   
 
 In study IV the adverse neonatal criteria included: neonatal mortality, umbilical arterial pH < 
7.00, 5 min Apgar score < 4). (Table 9) This composite index included the criteria for severe 
neonatal outcome from the term breech trial and from other former studies (12,165,166). 
 
In study V we evaluated adverse neurodevelopmental outcome in children at the age of four 
years according to mode of delivery in breech presentation at term. We studied the following 
characteristics: maternal age, nulliparity, smoking, maternal body mass index [BMI] > 30 
kg/m2, diabetes mellitus type I, gestational diabetes, maternal history of cesarean section, 
history of assisted reproduction technology, preeclampsia, oligohydramnios, needs for 
emergency cesarean section, gestational age at delivery, gender of neonate and birth weight 
in grams. (Table 8) 
 
The following neurodevelopmental outcomes were included: cerebral palsy, epilepsy, 
intellectual disability, and sensor-neural defects including visual impairment and deafness, 
speech or language problems and hyperactivity. The data was received from the Hospital 
Discharge Register using the ICD-10 codes for neurologic diagnoses (Table 9). Diagnoses 
were made based on medical history, ultrasonography, and MRI data as required, and 
multidisciplinary evaluations in secondary or tertiary pediatric neurology units. The age of 
four was chosen because cerebral palsy is usually diagnosed within the first two years and 
practically always by the age of three to four years (167). The ICD-10 code of cerebral palsy 
is reported to the Hospital Discharge Register immediately after diagnosis. All Finnish 
children undergo mandatory physical examinations during their childhood at state child 
health clinics; thus, neurological disorders are consistently recognized by the age of four 
(168). Maternal, pregnancy related, fetal and neonatal factors and characteristics were 
reviewed in relation with adverse neurodevelopmental outcome among children (Table 8). 
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Table 8: Reviewed exposures and objects of the studies 
 
^ (Birth weight < 2SD) 
*BMI = Body mass index 
gws = gestational week 
 
 
Table 9: Maternal, perinatal and children´s neurodevelopmental outcomes  
Study I Study II Study III Study IV Study V 
     
Breech presentation Umbilical arterial pH < 7.00 Birth trauma  Neonatal mortality < 7 d Umbilical arterial pH <7.00 
 Umbilical arterial BE ≤ -12 mmol/L Subdural hematoma Umbilical arterial pH < 7.00 5 min Apgar score <7 
 5 min Apgar score <7  Seizures occurring at < 24 h 5 min Apgar score < 4 Cerebral palsy  
 NICU >24 hours Apgar score < 4 at 5 min  Epilepsy  
 Metabolic acidosis  Umbilical arterial pH <7.00  Intellectual disability  
 Neonatal encephalopathy Umbilical arterial BE ≤ -12 mmol/L  Autism  
 Intrapartum stillbirths Umbilical arterial BE ≤ -15 mmol/L  Speech/ language problems  
 Birth trauma Neonatal mortality  Visual defects  
 Umbilical arterial pH Fetal mortality  Auditory defects  
 Neonatal mortality Tube feeding ≥ 4 days   Hyperactivity  
 Hospital stay post partum  (d) NICU≥ 4 days   
 Cesarean section Hypotonia ≥ 2 hours   
 Intrapartum cesarean section rate Stupor   
 Maternal blood loss (ml) Decreased response to pain   
  Coma   
  Intubation ≥ 24 hours   
  Ischemic encephalopathy   
Hours = h 
Minutes = min 
Potential of hydrogen = pH 
Base excess = BE 
Days = d 
Milliliter = ml 
Study I Study II Study III Study IV Study V 
Maternal age Maternal age  Maternal age Maternal age  Maternal age  
Parity Nulliparity Nulliparity Nulliparity Nulliparity 
Smoking Gestational age at delivery Gestational age at 
delivery 
Gestational age at delivery Smoking 
BMI ≥ 30 kg/m2 Maternal height BMI ≥ 30 kg/m2 Maternal smoking  BMI ≥ 30 kg/m2 
Diabetes mellitus type I  Maternal diabetes Maternal height BMI ≥ 30 kg/m2 Diabetes mellitus type I 
Gestational diabetes II delivery stage duration Gestational diabetes Diabetes mellitus type I Gestational diabetes 
History of cesarean section History of cesarean 
section  
History of cesarean 
section 
Gestational diabetes  History of cesarean section 
History of infertility Maternal hypertonia Maternal hypertonia Diabetes mellitus type II History of infertility 
Preeclampsia Induction of labor Pelvimetry History of cesarean section Preeclampsia 
Oligohydramnios Intrapartum cesarean 
section 
Epidural anesthesia History of assisted reproduction 
technology 
Oligohydramnios 
Placenta previa Neonatal gender (male) Augmentation Preeclampsia Emergency cesarean 
section 
Fetal growth restriction^  Birth weight in grams II delivery stage duration Oligohydramnios Gestational age at delivery 
Fetal sex (male)  Neonatal gender (male) Post term pregnancies  > 40 gws Neonatal gender (male) 
Birth weight in grams  Birth weight in grams Epidural anesthesia Birth weight in grams 
Congenital malformations  Birth weight <2500g Uterus rupture  
Stillbirth before labor  Birth weight 2500-4000g Fetal growth restriction^  
  Birth weight >4000g Neonatal gender (male)  
   Birth weight in grams  
   Macrosomia (>4500 grams)  
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Statistical analysis 
In study I, IV and V statistical analyses were undertaken using the Statistical Package for the 
Social Science Versions 17, 21 and 23, (SPSS Inc. Chicago, IL, USA).  Qualitative variables 
were reported by using percentages. Continuous variables were reported by using medians, 
ranges and means. Categorical data was analyzed by Chi-square test when appropriate; 
Fisher´s exact probability test was employed if the sample size was too small for the Chi-
square test. To compare continuous variables, Student´s t-test was applied for normal 
distributions and Mann- Whitney U-test for other type of distributions. Only valid 
percentages were calculated. A probability value (p-value) < 0.05 was considered statistically 
significant. In study I, IV and V a multivariate logistic regression analysis was performed to 
adjust outcome variables for potential cofounding factors.  
 
In study II and III statistical analyses were undertaken using SAS 9.2. (SAS-Institute, Cary, 
USA). For study II categorical variables were compared using the Chi-square test. The 
Wilcoxon signed rank test was used to compare continuous variables. A p value of 0.05 was 
considered significant. In study III continuous variables were reported by using medians, 
ranges and means. Categorical data was analyzed by Chi-square test or Fisher´s exact 
probability test. To compare continuous variables, Student´s t-test was applied for normal 
distributions and Mann- Whitney U-test for other type of distributions. Only valid 
percentages were calculated. A probability value (p-value) < 0.05 was considered statistically 
significant. For study II and III a stepwise regression model was used for adjustment. In study 
I, IV and V multivariate logistic regression analysis and 95 % CIs were used to evaluate the 

















Breech presentation and obstetric risk factors 
The prevalence of breech presentation of the fetus at term was 2.2 % in this study. Women 
with a fetus in breech presentation at term were significantly more often nulliparous [aOR] 
2.68 (2.58 – 2.79)]. The percentage of women with a BMI greater than 30 kg/m2 was lower in 
women with a fetus in breech presentation compared to women with a fetus in vertex 
presentation (10.3 % versus 11.5 %). The age of women with a fetus in breech presentation at 
term was higher (mean age 30.4 years) compared to women with a fetus in vertex 
presentation (mean age 30.1 years). 
 
In addition, women with a fetus in breech presentation had, compared to women with a fetus 
in cephalic presentation; more often a preceding cesarean delivery [aOR 2.13 (95 % CI 1.98 – 
2.29)] and suffered from gestational diabetes in the ongoing pregnancy [aOR 1.06 (95 % CI 
1.00 – 1.13)]. The fetuses in breech presentation compared to fetuses in cephalic presentation 
had significantly more congenital anomalies [aOR 2.01 (95 % CI 1.92 – 2.11)], were 
suffering more often from intrauterine stillbirth [OR 2.12 (95 % CI 1.98–2.28)], were more 
often female [aOR 0.78 (95 % CI 0.75–0.81)], had growth restriction [aOR 1.19 (95 % CI 
1.07 – 1.32)] and oligohydramnios [aOR 1.42 (95 % CI 1.27 – 1.57)]. (Table 10) 
Maternal and neonatal outcome in induced breech labors at term 
In study II 73 women with a fetus in breech presentation at term were induced and 195 
women attempted a spontaneous vaginal breech delivery. Induction of labor was associated 
with an increased intrapartum cesarean section rate compared to deliveries with a 
spontaneous onset of labor (36 % versus 20 %, P < 0.01). However, an induction of labor in 
breech presentation was not associated with an increased adverse perinatal or maternal 
outcome when compared to the outcome of patients with a trial of spontaneous vaginal 
breech labor (Table 11). 
 
Labor induction was also associated with a longer active second delivery stage (means 34 
versus 18 minutes P < 0.01), higher gestational weeks at delivery (means 39.9 versus 39.6 
weeks, P < 0.05) and the gestational duration equal to or higher than 41 gestational weeks (36 
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% versus 12 %, P < 0.01). Women with induced labor were more often suffering from 
hypertension (11 % versus 3.6 %, P < 0.05).  
Risk factors for adverse outcome in vaginal breech labor at term  
In study III we included 776 women that attempted a vaginal breech delivery. In total 38 
neonates (4.9 %) born out of these attempted vaginal breech deliveries had an adverse 
perinatal or neonatal outcome, whereas 738 neonates did not have an adverse outcome. One 
intrapartum death occurred. The perinatal mortality rate in women undergoing a trial of 
vaginal breech delivery at term was 0.13 %. The labor of the deceased child was induced in 
gestational week 41+0. The mother delivered a stillborn baby during an emergency cesarean 
section in the first phase of labor. The fetus suffered from nuchal cord complications.  
 
Three intrapartum risk factors for adverse peri- and neonatal outcome were found. A second 
delivery stage (active) lasting less than 40 minutes (Figure 18) [aOR 0.34 (0.15 - 0.79)] and a 
higher intrapartum cesarean section rate [aOR 0.07 (0.01 - 0.34)] had protective 
characteristics. The cesarean section rate was lower in the group of neonates with adverse 
outcome (5.3 %), compared to the cesarean section rate in the group of neonates born without 
an adverse outcome (24.3 %). The application of epidural anesthesia was associated with a 
higher adverse outcome rate in vaginal breech delivery [aOR 2.88 (1.08 - 7.70)].  
 
During study IV 10 057 women delivered a singleton fetus in breech presentation at term. 
Out of these 4805 women attempted a vaginal breech labor at term, 35 % delivering by 
cesarean section and 65 % vaginally. 73 (1.5 %) children born after a trial of vaginal delivery 
had a severe adverse perinatal outcome (Table 11). 
 
In study IV adverse perinatal outcome was related to fetal growth restriction (aOR, 2.94; 95 
% CI 1.30 - 6.67), gestational diabetes (aOR, 2.89; 95 % CI 1.54 - 5.40), a history of cesarean 
section (aOR, 2.94; 95 % CI 1.28 - 6.77), oligohydramnios (aOR, 2.94; 95 % CI 1.15 – 7.81), 
epidural anesthesia (aOR, 2.20; 95 % CI 1.29 – 3.75) and nulliparity (aOR, 1.84; 95 % CI 
1.10 - 3.08). To our surprise no correlation was found to macrosomia, higher maternal age, 
maternal BMI > 30 kg/m2, diabetes mellitus type I/II, maternal smoking, higher gestational 
age, neonatal sex, preeclampsia, birth weight, assisted reproduction technology and post term 
pregnancies (Table 10). 
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Figure 18. Relation of the duration of the active II delivery stage in minutes compared to 

























Table 10: Associated factors with breech presentation and associated risk factors for adverse 
neonatal outcome in a trial of vaginal breech delivery 
  
- not significant  
NA nota applicable 
*unadjusted OR 
** defined as < -2SD 
*** defined as <=10th percentile 






Exposures/characteristics Study I Study III Study IV 
 aOR (95 % CI) aOR (95 % CI) aOR (95 % CI) 
Maternal increased age (mean age in years) 1.03 (1.03 – 1.04) - - 
Maternal height NA - NA 
Nulliparity 2.68 (2.58 – 2.79) - 1.84 (1.10 - 3.08)  
BMI > 30 kg/m2 0.89 (0.84 – 0.95) NA  - 
Smoking during pregnancy - NA - 
Gestational age at delivery (weeks) NA - - 
Assisted reproduction technology - NA - 
History of cesarean section 2.13 (1.98 – 2.29) - 2.94 (1.28 - 6.77)  
Diabetes mellitus type I  - NA - 
Diabetes mellitus type II NA NA - 
Gestational diabetes 1.06 (1.00 – 1.13) - 2.89 (1.54 - 5.40)  
Congenital malformations 2.01 (1.92 – 2.11) NA NA 
Stillbirth 2.12 (1.98 – 2.28)* - NA 
Pelvimetry NA - - 
Attempted vertex version NA  - NA 
Preeclampsia/Hypertension  - - - 
Oligohydramnios 1.42 (1.27 – 1.57) -# 2.94 (1.15 - 7.81)  
Polyhydramnios -# -# -# 
Fetal growth restriction 1.19 (1.07 – 1.32)** -*** 2.94 (1.30 - 6.67)** 
Fetal/neonatal gender (male) 0.78 (0.75 – 0.81) - - 
Birth weight in grams NA - - 
Macrosomia (>4500g) NA NA NA 
Placenta previa - NA NA 
Epidural anesthesia NA 2.88 (1.08 – 7.70)  2.20 (1.29 - 3.75) 
Intrapartum cesarean section NA 0.07 (0.01 – 0.34) NA 
II delivery stage < 40min NA 0.34 (0.15 - 0.79) NA 
Augmentation NA - NA 
Post term pregnancies  > 40 week NA NA  - 
Uterus rupture NA NA  - 
Induction of labor NA - NA 
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Long-term outcome of children at the age of four according to the mode of birth 
During the study V 8374 children were delivered in breech position at term in Finland. 
Among them 4467 (53.3 %) infants were delivered by planned cesarean section and 3907 
(46.7 %) underwent a trial of vaginal labor.  
Out of all infants born in breech presentation a total of 275 (3.3 %) suffered from an 
abnormal neurodevelopment at the age of four.  From the infants born after an attempted 
vaginal breech delivery 133 (3.4 %) suffered from an abnormal neurodevelopment at the age 
of four compared to 142 (3.2 %) infants delivered by planned cesarean section [OR 1.06; 95 
% CI 0.74-1.52].  The neurological outcome is summarized in Table 11. Five of the infants 
born by attempted vaginal breech delivery suffered from cerebral palsy, compared to six in 
the planned cesarean group [OR 1.31; 95 % CI 0.28-6.07]. Epilepsy was diagnosed in 23 
children in the planned vaginal labor group (0.59 %) and in 23 in the planned cesarean 
section group (0.51 %) [OR 1.39; 95 % CI 0.62-3.14]. No significant differences were found 
when comparing the trial of vaginal breech labor group to the planned cesarean section group 
for the other variables of adverse neurodevelopment. (Table 11) A trial of vaginal breech 
labor was associated with an increased adverse short-term outcome including a significantly 
lower umbilical artery pH and a lower 5 min Apgar score (Table 11).  
 
Table 11: Short and long-term neonatal outcomes after a trial of vaginal breech labor 
(TVBL)  





TVBL TVBL TVBL PCS  
 % % % % % % OR (95 % CI) 
Umbilical artery pH < 7.00 0 2.6 1.8 0.9 1.2 0.1 8.9 (3.13 - 25.08) 
5 min Apgar score ≤ 6 1.4 1.5 2.7* - 3.1 1.2 2.61 (1.86 - 3.65) 
5 min Apgar score < 4 - - 1.02 0.6 - - - 
Neonatal mortality 0-28 days  1.4 0 0.13 0.1 0.08 0 0.95 (0.29 - 3.12) 
Cerebral palsy - - - - 0.13 0.13 1.31 (0.28 - 6.07) 
Epilepsy - - - - 0.59 0.51 1.39 (0.62 - 3.14) 
Intellectual disability - - - - 0.28 0.13 1.26 (0.45 - 3.56) 
Autism - - - - 0.13 0.22 0.20 (0.02-1.60) 
Speech or language problems - - - - 1.07 1.03 1.21 (0.73-2.00) 
Visual defects - - - - 1.10 1.35 0.68 (0.36-1.29) 
Auditory defects - - - - 0.33 0.25 1.52 (0.59-3.90) 
Hyperactivity - - - - 0.08 0.13 1.03 (0.19-5.55) 
[TVBL] Trial of vaginal breech labor  
[PCS] Planned cesarean section  




Our study showed that the prevalence of breech presentation was 2.2 % for all singleton 
pregnancies at term in Finland. We found that breech presentation was associated with 
various well-known obstetric risk factors for adverse peri- and neonatal outcome such as 
nulliparity, previous cesarean section and congenital anomaly, fetal growth restriction, 
gestational diabetes, increased maternal age and oligohydramnios. Equally importantly, our 
results showed that breech presentation before the onset of labor was associated with an 
increased antepartum stillbirth rate. 
 
We found that an induction of breech labor in well-selected pregnant term women was not 
associated with a higher rate of neonatal morbidity or mortality and that the induced breech 
labor for selected women at term had the same favorable neonatal outcomes compared to 
spontaneous vaginal breech deliveries. In other words, an induction of labor while the fetus is 
in breech presentation is feasible for a well-selected population. Induction of labor was, 
however, associated with an increased intrapartum cesarean section rate in addition to a 
longer second stage of delivery. 
 
With our results from the Helsinki University Central Hospital database (Study III), we 
demonstrated that an adverse neonatal outcome was associated with intrapartum risk factors 
such as a prolonged active second delivery stage, epidural anesthesia and a low intrapartum 
cesarean section rate. The analysis of the Finnish national birth register confirmed that the 
use of epidural anesthesia during breech vaginal trial was associated with a higher risk of 
adverse neonatal outcome (Study IV). This database includes all pregnant women who had a 
vaginal breech trial at term. In addition, the results showed that adverse neonatal outcome in 
vaginal breech labor at term is correlated with pre-partum risk factors like nulliparity, 
cesarean section in a previous pregnancy, oligohydramnios, fetal growth restriction and 
gestational diabetes. These results show how important the selection process of the women 
for vaginal breech delivery is.  
 
Finally, our results from study V showed that the long-term neurological outcome of children 
at the age of four, born after a trial of vaginal breech labor at term, was not different from the 
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children born by planned cesarean section.  Children with growth restriction and congenital 
anomalies were excluded from the study.  
 
Strengths and limitations of the study 
The strengths of our studies include the well-characterized study cohorts. Our studies were 
performed in Finland, a country with a homogenous population, where health care insurance 
covers all citizens. Furthermore, our study population consisted of the entire nation or a solid 
reflection of it. The maternity clinics reach 99.7 % of all pregnant women (169).  In Finland, 
pregnant women have approximately between 11 and 15 appointments with a health care 
professional (nurse, midwife or doctor) during pregnancy. A first trimester screening for 
chromosomal abnormalities and pregnancy dating is offered to all women as well as second 
trimester fetal organs scan with a screening for growth deficiency. Attending the 
appointments is mandatory to be eligible for maternity benefits and 90 % of all women 
participate in the voluntary screening program. Women with a fetus in breech presentation 
are offered an external version at 35-36 gestational weeks. After delivery the children’s 
health and development is followed up in child health clinics up to school age.  
 
Nearly all deliveries (99.7 %) in Finland take place in a hospital (46). All delivery hospitals 
have the facilities for cardiotocography and fetal ultrasound examination and all of them have 
a 24/7 service for anesthesia, pediatrics and obstetrics. Obstetricians are trained over a five-
year period in the five university hospitals of Finland and follow similar guidelines, which 
are provided by the National Gynecologic Society and the medical authorities (164). Finnish 
national registers have good coverage (164). The data of less than 0.1 % of all newborns is 
missing in the National Medical Birth Register and missing data is obtained from the Central 
Population Register and the Cause of Death Register (168). The Hospital Discharge Register 
was used to collect data on diagnoses related to pregnancy, delivery and the 
neurodevelopment of the children born in breech presentation. Reporting to the register is 
mandatory for all public and private clinics. The validity of the study results is good as the 
care of pregnant women is equal nationwide and happens in a modern obstetric setting.  
 
The major limitations of our studies are their retrospective design. Some might claim that the 
small number of patients enrolled to the case groups of study II and III are limitations, but 
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taking into account that breech delivery and induction of labor while the fetus is in breech 
presentation are rare, our case groups are quite reasonable in size. Further limitations for 
study I, IV and V were that variables were restricted to databank availability. Because of the 
restricted data availability register studies like ours are not able to evaluate all delivery 
aspects, for example more specified maternal complications like postpartum infections, 
vaginal lacerations and long-term complications including urinary incontinence or 
complications for future pregnancies. 
Interpretation of the study 
Breech presentation of the fetus at term 
We showed in study I that fetuses in breech presentation have a twice as high risk of 
suffering an intrauterine stillbirth. This is not surprising based on our demonstration that 
breech presentation at term is associated with known obstetric risk factors.  
 
Nulliparous women had a 2.7-times higher risk of having a fetus in breech presentation and 
women with a history of cesarean section have a 2.1-times higher risk of having a fetus in 
breech position. Fetuses in breech presentation had a two times higher risk of being 
diagnosed with a congenital anomaly, a 1.4 times higher risk of suffering from 
oligohydramnios and a 1.2-times higher risk of being growth restricted.  
 
Our data supports earlier studies that have shown an increased antepartum stillbirth rate in 
breech presentation at term compared to the rate in pregnancies with the fetus in vertex 
presentation (9,48). We were able to confirm that nulliparity is a risk factor for breech 
presentation (4,9). Most likely the reason for this is a firm abdominal and uterine wall, due to 
which the fetus is more restricted in its movements (4). Nulliparity is further associated with 
a prolonged second stage of labor (170) and with adverse neonatal outcome (171) as detected 
in Study III and IV. Our study showed that a history of cesarean section is also associated 
with breech presentation in a succeeding term pregnancy. Preceding cesarean delivery is a 
risk factor for uterine rupture, emergency peripartum hysterectomy and placental 
abnormalities (22,172) and is therefore a risk factor for adverse neonatal and maternal 
outcome (22,172,173). However, our results only showed an association between breech 
presentation of the fetus and preceding cesarean delivery, not an association between adverse 
neonatal outcome and the common complications of an earlier cesarean delivery. 
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We were able to confirm that breech presentation at term is more often associated with 
congenital fetal anomalies than in cephalic presentation (58,174). Fetuses with congenital 
anomalies most likely suffer from underlying problems in fetal morphogenesis (they might fit 
better into the uterine cavity in breech presentation) and/or neuromuscular functional 
problems (58,174).  
 
Our results demonstrated that breech presentation at term is associated with oligohydramnios 
and fetal growth restriction. Oligohydramnios is a known risk factor for breech presentation 
at term (175,176), most likely caused by an impediment of the fetal rotation. 
Oligohydramnios is a known obstetric risk factor as it might indicate placental insufficiency 
(177). Growth restricted fetuses might suffer from lower neurologic and muscular control, as 
fetal growth restriction is associated with a lower rate of fetal movement (178-180). This 
reduced amount of movement may impede the fetus from rotating into vertex presentation. 
Reduced fetal movements are a known risk or associated factors for adverse peri- and 
neonatal outcome (180,181), but reduced fetal movements may also suggest that the fetus is 
suffering while still in the womb. 
 
In our study gestational diabetes was found to be associated with a slightly increased risk for 
breech presentation at term, as shown before (182). It is a known risk factor for adverse 
perinatal outcome, like macrosomia, jaundice preeclampsia and postnatal hypoglycemia 
(173,183,184). However, the association between gestational diabetes and breech 
presentation at term might be due to fetal macrosomia caused by gestational diabetes, as 
macrosomic fetuses might be less capable of moving within the uterus. Polyhydramnios is 
often claimed as a risk factor for breech presentation of the fetus at term, as it might increase 
abnormal fetal movements; however this association could not be confirmed in reasoned 
published papers (4-6,8,9,47,58); also our results could not confirm it as a risk factor for 
breech presentation. 
 
Induction of labor while the fetus is in breech presentation at term 
We demonstrated that an induction of labor while the fetus is in breech position is feasible. 
The rate of successful vaginal deliveries was slightly lower in induced labor compared to 
spontaneous breech labor. However, induced vaginal breech delivery has the same favorable 
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neonatal outcomes as spontaneous breech delivery at term.  Our findings regarding the 
induction of breech labor are consistent with earlier and recently performed studies (123-
129). 
 
Despite the clear results of all recent studies the guidelines of the Royal College of 
Obstetricians and Gynaecologists (31) and the Society of Obstetricians and 
Gynaecologists  (41) do not recommend induction of labor while the fetus is in breech 
presentation. The guidelines of the American College of Obstetricians and Gynecologists, the 
Deutsche Gesellschaft für Gynäkologie und Geburtshilfe and the Organisme professionnel 
des médecins exerçant la gynécologie et l'obstétrique en France make no recommendation at 
all on the topic (28,30,79). 
 
Pre- and intrapartum criteria for a safe vaginal breech labor 
In our studies we showed both new and old antenatal (nulliparity, a previous cesarean 
delivery, gestational diabetes, fetal growth restriction and oligohydramnios) and intrapartum 
(epidural anesthesia, an active second delivery stage lasting more than 40 minutes and a low 
intrapartum cesarean section rate) risk factors for adverse outcome in a trial of vaginal labor.  
 
Nulliparity was associated with an increased adverse peri- and neonatal outcome. The results 
showed that pregnant women, who are expecting their first child have a 1.8 times higher risk 
for adverse peri- and neonatal outcome compared to multiparous women. Nulliparity is a 
known risk factor for breech presentation and is also known to be associated with adverse 
pregnancy outcomes like hypertension, preeclampsia, preterm delivery, smallness for 
gestational age and a prolonged second delivery stage (170,185-196). Fetuses born of 
pregnancies with preeclampsia, maternal hypertension or a fetus that is small for gestational 
age might not have the reserves to cope with a trial of vaginal breech delivery. 
 
The risk for adverse outcome was nearly three times higher, if the woman had a history of 
preceding cesarean deliveries. A previous cesarean delivery is a known risk factor for adverse 
outcome as it is associated with a higher perinatal mortality, birth asphyxia and sepsis, 
uterine rupture and a prolonged labor (22,172,197-201). A previous cesarean delivery is a 




Our results showed that gestational diabetes was associated with a three times higher risk for 
adverse neonatal outcome in breech presentation. Gestational diabetes is a known risk factor 
for increased perinatal mortality, fetal macrosomia and preeclampsia (173,183,184). The 
placenta might changes in structure and function through hyperglycemia. These changes 
include villous immaturity, villous fibrinoid necrosis, chorangiosis, and increased 
angiogenesis. Earlier research suggests that diabetic placental changes are associated with 
inflammation and oxidative stress that can lead to chronic fetal hypoxia. (202-205).  Fetuses 
that suffer from hypoxia in the womb will most likely not endure a trial of vaginal breech 
delivery. 
 
The risk for adverse neonatal outcome was nearly three times higher if the fetus suffered 
from growth restriction.  Fetal growth restriction is one of the most common reasons for 
antepartum stillbirths and adverse perinatal outcome as shown by the ACOG guidelines and 
others (177,179,181,206-211).  
 
Oligohydramnios was associated with a nearly three times higher risk for adverse neonatal 
outcome including low Apgar points and low umbilical arterial pH <7.00 as shown by a 
meta-analysis (211).  Oligohydramnios might cause a higher risk for adverse outcome based 
on placental insufficiency or umbilical cord compression (177,212). Fetal growth restriction 
like oligohydramnios could be a sign of a compromised fetus, which should not be eligible 
for a trial of vaginal breech labor.  
 
We were able to identify epidural anesthesia, an active second delivery stage lasting more 
than 40 minutes and a low intrapartum cesarean section rate as intrapartum risk factors for 
adverse peri- and neonatal outcomes. Epidural anesthesia increased the risk for adverse 
neonatal outcome [aOR 2.2 (study III) and aOR 2.9 (study IV)]. Epidural anesthesia is 
associated with a prolonged second delivery stage and with temperature elevation, which has 
been associated with adverse outcome in neonates in term pregnancies (100-102,195), but it 
has to be considered, that epidural anesthesia is only a sign of a slowly progressing labor, not 
the reason for adverse outcome. 
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In study III we demonstrated that a prolonged second delivery stage, epidural anesthesia and 
a low intrapartum cesarean section rate are intrapartum risk factors for adverse peri- and 
neonatal outcome in trial of breech delivery. Earlier studies have shown that the duration of 
the active second delivery stage lasting more than 60 minutes increases the risk for adverse 
neonatal outcome (12,213). The most common reason for a prolongation of the active second 
delivery stage are inadequate uterine contractions (214). Another reason for the delay in labor 
is the insufficient descent of the fetus due to fetal-maternal disproportion or umbilical cord 
complications (like nuchal cord). The guidelines for breech delivery in Canada recommend a 
cesarean section if vaginal labor is not imminent after on hour of active pushing (41), 
whereas our data suggests that a second delivery stage of less than 40 minutes or even less 
than 30 minutes has a protective effect for normal neonatal outcome. A prolonged labor 
might cause more fetal head entrapment. The delayed delivery of the fetal head and the 
maneuvers needed to treat it are most likely the cause of the increased fetal morbidity.  
 
To our surprise we found a lower intrapartum cesarean section rate in the group with adverse 
perinatal outcome, as secondary cesarean section is a common risk factor for adverse fetal 
outcomes (214). The emergency cesarean section rate in the group with adverse outcome was 
low (5.3 %). This rate seems too low, as unfavorable vaginal breech labors (CTG changes, 
slow progress in labor) should be converted into cesarean section to safeguard the health of 
the neonates.  A cesarean section rate of 20 to 30 % when attempting vaginal breech delivery 
seems to be normal (215,216). However, the PREMODA study by Goffinet showed that 
selecting and managing vaginal deliveries carefully could safeguard a normal neonatal 
outcome, even though the cesarean section rates varied significantly among the centers (34).  
 
Neurological long-term outcome of children born in breech position  
Children born after a trial of vaginal breech labor have similar long-term outcomes as 
children born by planned cesarean section. A trial of vaginal breech labor was not associated 
with cerebral palsy, epilepsy, intellectual disability, autism, speech or language problems, 
visual or auditory defects or hyperactivity at the age of four, if conducted with women with 
low-risk breech pregnancies. Our findings are consistent with earlier findings 
(45,138,146,213,217). Neurodevelopmental disorders among offspring maybe caused by 
preconceptional factors, antenatal risk factors during the ongoing pregnancy and intrapartum 
factors including birth asphyxia (Table 12) (144). The aim of our study was to evaluate the 
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individual risk for adverse neurodevelopmental outcome at the age of four of children born 
after an attempted vaginal breech delivery. We excluded other possible risk factors for 
adverse neonatal outcome such as fetal growth restriction, multiple pregnancies, placental 
abruption and preterm delivery to investigate the individual risk for adverse 
neurodevelopmental outcome at the age of four years after a trial of vaginal breech labor.  
After the exclusion of these factors, children in both groups had similar neurodevelopmental 
long-term outcomes regardless of the mode of delivery. These results are consistent with 
earlier findings (146,213,217) as well as with recently published Norwegian data by Bjellmo 
(45). A follow-up study of the term breech trial children at two years of age could not find a 
difference regarding neurodevelopmental delay between the planned cesarean birth group 
(3.1 %) and the planned vaginal birth group (2.8 %) either (138). 
 
Nevertheless we have to admit that a trial of vaginal breech labor is associated with adverse 
short-term outcomes. The children in the vaginal trial group had a lower umbilical artery pH 
and lower 5-minute Apgar scores (12,51,218,219). Our data showed that the perinatal 
mortality rate in a trial of vaginal breech labor was 0.08 %, which is considerably lower than 
in the term breech trial (1.3 %) (12). The question arises why the neonates are suffering from 
adverse short-term morbidity but not from long-term morbidity? The answer is most likely 
linked to the fact that during a trial of vaginal breech labor fetuses suffer more often from 
cord compression, which results in an acute respiratory acidosis from which a healthy term 
newborn easily recovers but not a compromised fetus (for example a growth restricted fetus). 
 
Table 12: Possible risk factors for adverse neurodevelopmental disorders among offspring 
acquired before birth 
Risk factors for adverse neurodevelopmental disorders acquired during pregnancy 
Preconceptional Antenatal Intrapartum 
Maternal hypothyroidism  Congenital anomalies  Birth asphyxia 
Maternal hyperthyroidism  Preterm delivery Meconium aspiration  
Medications Fetal growth restriction Prolonged labor 
 Placental changes Instrumental deliveries 
 Placental abruption Abnormal fetal presentation 
 Infections   
 Maternal heart diseases   
 Preeclampsia  





Further studies for the prediction of adverse neonatal outcomes in breech delivery are needed: 
• The short and long-term outcomes of growth-restricted fetuses undergoing a trial of 
vaginal breech delivery should be studied. Also, the short and long-term outcomes of 
fetuses with fetal growth restriction below the < 10th and the 2nd percentile in breech 
presentation should be reviewed, to review if all growth restricted fetuses are at 
higher risk for adverse neonatal outcome. 
• Further studies on the effect of maternal diabetes and earlier cesarean delivery as risk 
factors for adverse outcomes are needed, to understand better their pathophysiology 
and to avoid complications. 
Preterm breech delivery needs further studies: 
• Outcome of vaginal delivery in extremely preterm (<28 weeks), very preterm (28 
to <32 weeks) and moderate to late preterm (32 to <37 weeks) breech delivery 
should be reviewed. 
• Neurodevelopmental outcome in preterm breech delivery needs further examination. 
Training 
• More education and training for health care staff, specifically obstetricians and 
midwifes, is needed to give women and fetuses optimal care during delivery and to 

















Breech presentation of the fetus at term was associated with a higher antepartum stillbirth 
rate and with possible risk factors that are in themselves associated with a higher perinatal 
mortality and morbidity compared to pregnancies with the fetus in vertex presentation. 
Fetuses in breech presentation at term should undergo an ultrasound examination for fetal 
malformations and should be reviewed for other risk factors for adverse fetal outcome before 
delivery. An induction of labor at term while the fetus in breech presentation is possible for a 
selected population of women since it was not associated with a higher fetal morbidity or 
mortality. We were able to show that the neonatal mortality and morbidity of the offspring 
undergoing a trial of vaginal breech labor was lower and not as high as claimed by the Term 
Breech Trial. An active second delivery stage lasting more than 40 minutes, a low 
intrapartum cesarean section rate and epidural anesthesia during labor were associated with 
higher neonatal morbidity. A trial of vaginal breech labor at term was not associated with an 
adverse neurodevelopmental outcome of the children at the age of four. 
 
As many guidelines state women should be counseled that vaginal breech delivery is 
associated with a slightly higher risk of perinatal mortality and morbidity compared to an 
elective cesarean section.  
 
Our study showed that it is important to select women carefully for a trial of vaginal breech 
labor and the significance of an adequate intrapartum management to avoid adverse neonatal 
short-term outcome. The study showed that adverse short-term morbidity after a trial of 
vaginal breech labor was not associated with adverse neurodevelopmental outcome at the age 
of four among offspring. Guidelines for breech presentation should be updated and doctors 
must continuously train related maneuvers and forceps deliveries for a safe vaginal breech 
labor.  
 
The radical changes in breech delivery management implemented after the publication of the 
Term Breech Trial might have been rushed and exaggerated, as the Term Breech Trial was a 
well-designed, but not a well-performed study. Elective cesarean section as a standard 
treatment for every breech presentation might be the wrong choice, as it is associated with a 
higher risk for the mother and her offspring during future pregnancies. Women and health 
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care professionals should have the possibility to choose the safest method to deliver a fetus in 
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